Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miglustat and ERT in Gaucher Disease Type IIIB
NCT02520934Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Jul 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of miglustat in Gaucher disease (GD) (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Purdue Pegboard test speed at 24 months. Status: unknown.
02
Drugs
miglustat
03
Conditions
Gaucher disease (GD)
Beyond the preview
Go deeper on NCT02520934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02520934.